Cardiovascular effects of dobutamine, norepinephrine and phenylephrine in isoflurane-anaesthetized dogs administered dexmedetomidine-vatinoxan

Vet Anaesth Analg. 2022 Nov;49(6):546-555. doi: 10.1016/j.vaa.2022.07.007. Epub 2022 Jul 31.

Abstract

Objective: To determine whether dobutamine, norepinephrine or phenylephrine infusions alleviate hypotension in isoflurane-anaesthetized dogs administered dexmedetomidine with vatinoxan.

Study design: Balanced, randomized crossover trial.

Animals: A total of eight healthy Beagle dogs.

Methods: Each dog was anaesthetized with isoflurane (end-tidal isoflurane 1.3%) and five treatments: dexmedetomidine hydrochloride (2.5 μg kg-1) bolus followed by 0.9% saline infusion (DEX-S); dexmedetomidine and vatinoxan hydrochloride (100 μg kg-1) bolus followed by an infusion of 0.9% saline (DEX-VAT-S), dobutamine (DEX-VAT-D), norepinephrine (DEX-VAT-N) or phenylephrine (DEX-VAT-P). The dexmedetomidine and vatinoxan boluses were administered at baseline (T0) and the treatment infusion was started after 15 minutes (T15) if mean arterial pressure (MAP) was < 90 mmHg. The treatment infusion rate was adjusted every 5 minutes as required. Systemic haemodynamics were recorded at T0 and 10 (T10) and 45 (T45) minutes. A repeated measures analysis of covariance model was used.

Results: Most dogs had a MAP < 70 mmHg at T0 before treatment. Treatments DEX-S and DEX-VAT all significantly increased MAP at T10, but systemic vascular resistance index (SVRI) was significantly higher and cardiac index (CI) lower after DEX-S than after DEX-VAT. CI did not significantly differ between DEX-S and DEX-VAT-S at T45, while SVRI remained higher with DEX-S. Normotension was achieved by all vasoactive infusions in every dog, whereas MAP was below baseline with DEX-VAT-S, and higher than baseline with DEX-S at T45. Median infusion rates were 3.75, 0.25 and 0.5 μg kg-1 minute-1 for dobutamine, norepinephrine and phenylephrine, respectively. Dobutamine and norepinephrine increased CI (mean ± standard deviation, 3.35 ± 0.70 and 3.97 ± 1.24 L minute-1 m-2, respectively) and decreased SVRI, whereas phenylephrine had the opposite effect (CI 2.13 ± 0.45 L minute-1 m-2).

Conclusions and clinical relevance: Hypotension in isoflurane-anaesthetized dogs administered dexmedetomidine and vatinoxan can be treated with either dobutamine or norepinephrine.

Keywords: dexmedetomidine; dobutamine; hypotension; norepinephrine; phenylephrine; vatinoxan.

Publication types

  • Randomized Controlled Trial, Veterinary

MeSH terms

  • Anesthetics, Inhalation*
  • Animals
  • Blood Pressure
  • Dexmedetomidine* / pharmacology
  • Dobutamine / pharmacology
  • Dog Diseases* / drug therapy
  • Dogs
  • Hypotension* / chemically induced
  • Hypotension* / drug therapy
  • Hypotension* / veterinary
  • Isoflurane*
  • Norepinephrine / pharmacology
  • Phenylephrine / pharmacology
  • Saline Solution / pharmacology

Substances

  • Isoflurane
  • vatinoxan
  • Dexmedetomidine
  • Dobutamine
  • Anesthetics, Inhalation
  • Phenylephrine
  • Norepinephrine
  • Saline Solution